In the present study, MCP-1 levels were found to be significantly higher in diabetic patients with asthma while no significant changes in eotaxin levels could be observed in T2D and/or asthma patients as compared with non-diabetic non-asthmatic controls. Here, CCL2 is linked to type 2 diabetes mellitus.